Association of immunohistochemical markers of tumor subtype with response to neoadjuvant chemotherapy and survival in patients with muscle-invasive bladder cancer

PURPOSE: A readily accessible biomarker to identify which patients with bladder cancer are more likely to respond to neoadjuvant chemotherapy (NAC) could help clinicians avoid unnecessary chemotherapy and prevent its subsequent complications in some patients. The primary objective of this study was...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Investig Clin Urol
Egile Nagusiak: Razzaghdoust, Abolfazl, Ghajari, Mahdi, Basiri, Abbas, Torbati, Peyman Mohammadi, Jafari, Anya, Fattahi, Mohammad-Reza, Salahi, Maryam, Mofid, Bahram
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: The Korean Urological Association 2021
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8100015/
https://ncbi.nlm.nih.gov/pubmed/33943049
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4111/icu.20200425
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak